Department of Urology, Urologic Cancer Center, National Cancer Center, Goyang, Korea.
Health Insurance Policy Research Institute, National Health Insurance Service, Wonju, Korea.
Cancer Med. 2019 Sep;8(11):4967-4975. doi: 10.1002/cam4.2382. Epub 2019 Jul 8.
In this study, we aimed to propose a validated prediction model for disease-free survival (DFS) after radical nephroureterectomy (RNU) in a Korean population with upper urinary tract urothelial carcinoma (UTUC).
We performed a retrospective review of 1561 cases of UTUC who underwent either open RNU (ONU, n = 906) or laparoscopic RNU (LNU, n = 615) from five tertiary Korean institutions between January 2000 and December 2012. Data were used to develop a prediction model using the Cox proportional hazards model. Prognostic factors were selected using the backward variable selection method. The prediction model performance was investigated using Harrell's concordance index (C-index) and Hosmer-Lemeshow type 2 statistics. Internal validation was performed using a bootstrap approach, and the National Cancer Center data set (n = 128) was used for external validation.
A best-fitting prediction model with seven significant factors was developed. The C-index and two Hosmer-Lemeshow type statistics of the prediction model were 0.785 (95% CI, 0.755-0.815), 4.810 (P = 0.8506), and 5.285 (P = 0.8088). The optimism-corrected estimate through the internal validation was 0.774 (95% CI, 0.744-0.804) and the optimism-corrected calibration curve was close to the ideal line with mean absolute error = 0.012. In external validation, the discrimination was 0.657 (95% CI, 0.560-0.755) and the two calibration statistics were 0.790 (P = 0.9397) and 3.103 (P = 0.5408), respectively.
A validated prediction model based on a large Korean RNU cohort was developed with acceptable performance to estimate DFS in patients with UTUC.
本研究旨在针对韩国上尿路上皮癌(UTUC)患者,建立并验证一种可用于预测根治性肾输尿管切除术(RNU)后无病生存(DFS)的预测模型。
我们对 2000 年 1 月至 2012 年 12 月期间,5 家韩国三级医疗机构的 1561 例接受开放式 RNU(ONU,n=906)或腹腔镜式 RNU(LNU,n=615)的 UTUC 患者进行了回顾性分析。采用 Cox 比例风险模型建立预测模型,采用向后变量选择法选择预后因素。采用 Harrell 一致性指数(C-index)和 Hosmer-Lemeshow 第二类统计量评估预测模型的性能。采用 bootstrap 方法进行内部验证,采用国家癌症中心数据集(n=128)进行外部验证。
建立了一个包含 7 个显著因素的最佳拟合预测模型。该预测模型的 C-index 和 2 个 Hosmer-Lemeshow 第二类统计量分别为 0.785(95%CI,0.755-0.815)、4.810(P=0.8506)和 5.285(P=0.8088)。内部验证的校正后最优估计值为 0.774(95%CI,0.744-0.804),校正后校准曲线接近理想线,平均绝对误差=0.012。在外部验证中,该模型的判别能力为 0.657(95%CI,0.560-0.755),2 个校准统计量分别为 0.790(P=0.9397)和 3.103(P=0.5408)。
本研究基于韩国大型 RNU 队列建立了一种验证有效的预测模型,该模型具有较好的性能,可用于预测 UTUC 患者的 DFS。